To more deeply investigate the biological underpinnings behind the seemingly beneficial NKG2A+ bias, we sought to understand how NKG2A+ CD8+ T cell tumor infiltrates differ from their NKG2C+ counterparts. The gene discussed is CD8A; the disease is neoplasm.